Home > COVID-19

Coronavirus (COVID-19)

The Center for Health Affairs, in coordination with the Ohio Department of Health (ODH), the Northeast Ohio county and city health departments, and member hospitals, is closely monitoring the 2019 novel coronavirus (nCoV) to ensure hospitals are prepared to care for potential nCoV patients while protecting their staff in the midst of a vigorous annual flu season.

As the coronavirus situation evolves daily, the most up-to-date Centers for Disease Control and Prevention guidance for hospitals can be found on the CDC website.

Visit CDC Website

The World Health Organization offers more coronavirus information and provides advice to countries and individuals on measures to protect health and prevent the spread of this outbreak.

Visit WHO Website

For the latest updates on COVID-19 activity in the state of Ohio, please visit the Ohio Department of Health. This is updated daily at 2:00 P.M. EST.

Visit ODH Website 

The AHA is keeping the healthcare field informed about COVID-19 vaccine development, distribution and other issues, as well as resources from the federal government and other public health stakeholders.

Visit AHA Website  


COVID-19 Leadership Series
In partnership with BrightTALK, the largest global platform for online educational talks and events, The Center for Health Affairs has launched its COVID-19 Leadership Series, webinars featuring leaders across the region and beyond who share their insights, lessons and perspectives on the pandemic. Events are free of charge and can be watched live or viewed afterward.

Latest Updates

COVID-19 Vaccine Distribution Info Now Available on Healthy Northeast Ohio Website
Healthy Northeast Ohio, the online resource designed to provide access to population health data, evidence-based practices and information about regional health resources and activities, has been updated with COVID-19 vaccine distribution information. Visit the Healthy NEO website to find details on vaccines from hospitals, community health centers and health departments in Northeast Ohio.

State of Ohio Recruiting Volunteers to Assist with COVID-19 Vaccinations
The state of Ohio is looking for qualified healthcare professionals to volunteer at COVID-19 vaccination events. Licensed individuals are encouraged to assist their community through the Ohio Responds Volunteer Registry. View the state's flyer and visit the Ohio Responds website for more details.

Progress Continues on COVID-19 Vaccines
The month of November has brought a dose of hope to a world waiting for a COVID-19 vaccine. On Nov. 20, Pfizer announced it is seeking emergency use authorization from the Food and Drug Administration for its vaccine, which it says 95% effective in a Phase 3 clinical trial. Similarly, on Nov. 16, Moderna Inc. revealed its vaccine appears to be 94.5% effective, according to preliminary data from an ongoing study. More recently, on Nov. 23, AstraZeneca announced it, too, has found its vaccine to be 90% effective in a Phase 3 trial. The Trump administration recently announced it is partnering with chain and independent community pharmacies to increase access to future COVID-19 vaccines, and Ohio Gov. Mike DeWine announced on Nov. 17 that The Center for Health Affairs’ member hospitals Cleveland Clinic and MetroHealth will be among 10 Ohio hospitals set to receive the COVID-19 vaccine after it is given emergency use authorization.

New Antibody Therapeutic Being Made Available
Ohio hospitals have begun receiving doses of Eli Lilly’s new monoclonal antibody therapeutic, bamlanivimab, which received emergency use authorization from the U.S. Food and Drug Administration Nov. 9 for the treatment of non-hospitalized patients with mild or moderate confirmed cases of COVID-19. On Oct. 28, the federal government announced a purchase of 300,000 doses of the therapeutic, which are being allocated to states by the U.S. Department of Health and Human Services (HHS) based on case and hospitalization data reported to HHS by hospitals. Ohio is receiving 3,420 doses and allocations are being divided into two phases, with the first going to hospitals and the second going to additional outpatient facilities.

Bamlanivimab is an infusion drug administered on an outpatient basis that is intended to prevent progression of disease. It requires a single dose and is most effective when administered early in infection. The allocation is intended for high-risk patients, which are those who meet at least one of a set of specific criteria including having chronic kidney disease, diabetes or immunosuppressive disease, or being age 65 or older, among others.

Ohio Department of Medicaid Lifts Prior Authorization Requirement for LTACs, SNFs
The Ohio Department of Medicaid announced Nov. 12 that effective immediately, Medicaid managed care organizations must lift all prior authorizations and pre-certifications for long-term acute care facilities and for all skilled nursing facility (SNF) admissions. In doing so, the state is seeking to remove barriers to care and reduce administrative burden on hospitals and SNFs as COVID-19 cases continue to surge rapidly across the state. This change will allow hospitals to more quickly and efficiently discharge patients who are ready to move to one of these types of facilities in order to open up space for a growing number of COVID-19 patients requiring hospitalization.

Contact Us

For more information or to contact ASPR Project Director Beth Gatlin, RN, MA-HSM, please call 800.362.2628 ext. 3665.


Join our distribution list to receive our monthly Quick Scan which features our recent news and upcoming events.

+ Subscribe